Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-05

FDA Approved: OXCARBAZEPINE — Original Application (Advagen Pharma Ltd.)

View source ↗

Summary

FDA approved the original application for oxcarbazepine by Advagen Pharma Ltd., enabling the generic product to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

ORIG AP for OXCARBAZEPINE (OXCARBAZEPINE)